Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

Completed · Not applicable

Conditions studied: Macular Hole, Retinal Detachment

In brief

The purpose of this study is to see if glaucoma eye drops (dorzolamide-timolol) have any effect on the duration of an intraocular gas bubble following pars plana vitrectomy.

Key facts

Study ID

NCT01257698

Run by

Mid Atlantic Retina

People needed

21

Starts

2010-02-01

Expected to finish

2013-06-01

Last updated by the study team

2019-09-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled for pars plana vitrectomy with intraocular gas tamponade with sulfur hexafluoride (e.g., retinal detachment, macular hole, other condition at the discretion of the investigator).
• Ability to provide written informed consent and comply with study assessments for the full duration of the study.

You may not qualify if…

• Prior trabeculectomy or tube shunt surgery.
• Current use of topical aqueous suppressants or other glaucoma medications.
• Aphakia or presence of anterior chamber intraocular lens implant.
• Known allergy or contraindication to sulfa or beta-blocker use (e.g., asthma, chronic obstructive pulmonary disease, bradycardia).

Where it is running

• Wills Eye Institute — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.